Polymorphism in Xeroderma Pigmentosum Complementation Group C Codon 939 and Aflatoxin B1-Related Hepatocellular Carcinoma in the Guangxi Population

被引:56
作者
Long, Xi-Dai [1 ,2 ]
Ma, Yun [3 ]
Zhou, Yuan-Feng [2 ]
Ma, Ai-Min [2 ]
Fu, Guo-Hui [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Dept Pathol, Shanghai 200025, Peoples R China
[2] Youjiang Med Coll Nationalities, Dept Pathol, Baise, Peoples R China
[3] Guangxi Med Univ, Dept Pathol, Nanning, Peoples R China
基金
国家高技术研究发展计划(863计划);
关键词
NUCLEOTIDE-EXCISION-REPAIR; DNA-REPAIR; BREAST-CANCER; XPC POLYMORPHISMS; DAMAGE RECOGNITION; GENE POLYMORPHISMS; LUNG-CANCER; RISK; CHINA; P53;
D O I
10.1002/hep.23807
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Genetic polymorphisms in DNA repair genes may influence individual variations in DNA repair capacity, and this may be associated with the risk and outcome of hepatocellular carcinoma (HCC) related to aflatoxin B1 (AFB1) exposure. In this study, we focused on the polymorphism of xeroderma pigmentosum complementation group C (XPC) codon 939 (rs#2228001), which is involved in nucleotide excision repair. We conducted a case-control study including 1156 HCC cases and 1402 controls without any evidence of hepatic disease to evaluate the associations between this polymorphism and HCC risk and prognosis in the Guangxi population. AFB1 DNA adduct levels, XPC genotypes, and XPC protein levels were tested with a comparative enzyme-linked immunosorbent assay, Taq-Man polymerase chain reaction for XPC genotypes, and immunohistochemistry, respectively. Higher AFB1 exposure was observed among HCC patients versus the control group [odds ratio (OR) = 9.88 for AFB1 exposure years and OR = 6.58 for AFB1 exposure levels]. The XPC codon 939 Gln alleles significantly increased HCC risk [OR = 1.25 (95% confidence interval = 1.03-1.52) for heterozygotes of the XPC codon 939 Lys and Gln alleles (XPC-LG) and OR = 1.81 (95% confidence interval = 1.36-2.40) for homozygotes of the XPC codon 939 Gln alleles (XPC-GG)]. Significant interactive effects between genotypes and AFB1 exposure status were also observed in the joint-effects analysis. This polymorphism, moreover, was correlated with XPC expression levels in cancerous tissues (r = 0.369, P < 0.001) and with the overall survival of HCC patients (the median survival times were 30, 25, and 19 months for patients with homozygotes of the XPC codon 939 Lys alleles, XPC-LG, and XPC-GG, respectively), especially under high AFB1 exposure conditions. Like AFB1 exposure, the XPC codon 939 polymorphism was an independent prognostic factor influencing the survival of HCC. Additionally, this polymorphism multiplicatively interacted with the xeroderma pigmentosum complementation group D codon 751 polymorphism with respect to HCC risk (ORinteraction = 1.71). Conclusion: These results suggest that the XPC codon 939 polymorphism may be associated with the risk and outcome of AFB1-related HCC in the Guangxi population and may interact with AFB1 exposure in the process of HCC induction by AFB1. (HEPATOLOGY 2010;52:13011309)
引用
收藏
页码:1301 / 1309
页数:9
相关论文
共 36 条
  • [31] +49G &gt; A polymorphism in the cytotoxic T-lymphocyte antigen-4 gene increases susceptibility to hepatitis B-related hepatocellular carcinoma in a male Chinese population
    Gu, Xing
    Qi, Peng
    Zhou, Feiguo
    Ji, Qiang
    Wang, Hao
    Dou, Tonghai
    Zhao, Yunpeng
    Gao, Chunfang
    HUMAN IMMUNOLOGY, 2010, 71 (01) : 83 - 87
  • [32] Nucleotide changes related to hepatocellular carcinoma in the enhancer 1/x-promoter of hepatitis B virus subgenotype C2 in cirrhotic patients
    Cho, Eun-Young
    Kim, Haak-Cheoul
    Choi, Chang-Soo
    Shin, Sae Ron
    Park, Channy
    So, Hong-Seob
    Kim, Hyung Jin
    Park, Raekil
    Cho, Ji Hyun
    Moon, Hyung Bae
    CANCER SCIENCE, 2010, 101 (08): : 1905 - 1912
  • [33] Excision repair cross-complementation group 1 codon 118 polymorphism, micro ribonucleic acid and protein expression, clinical outcome of the advanced gastric cancer response to first-line FOLFOX-4 in Qinghai-Tibetan plateau population
    Qi, Yu-Juan
    Cui, Sen
    Yang, Ying-Zhong
    Han, Jing-Qi
    Cai, Bao-Jia
    Sheng, Cun-Fang
    Ma, Yan
    Wuren, Tana
    Ge, Ri-Li
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2013, 9 (03) : 410 - 415
  • [34] Binding of HIV-1 Vpr Protein to the Human Homolog of the Yeast DNA Repair Protein RAD23 (hHR23A) Requires Its Xeroderma Pigmentosum Complementation Group C Binding (XPCB) Domain as Well as the Ubiquitin-associated 2 (UBA2) Domain
    Jung, Jinwon
    Byeon, In-Ja L.
    DeLucia, Maria
    Koharudin, Leonardus M. I.
    Ahn, Jinwoo
    Gronenborn, Angela M.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (05) : 2577 - 2588
  • [35] XRCC1 rs25487 genetic variant and TP53 mutation at codon 249 predict clinical outcomes of hepatitis B virus-related hepatocellular carcinoma after hepatectomy: A cohort study for 10 years' follow up
    Yu, Long
    Liu, Xiaoguang
    Han, Chuangye
    Lu, Sichong
    Zhu, Guangzhi
    Su, Hao
    Qi, Wei
    Liao, Xiwen
    Peng, Tao
    HEPATOLOGY RESEARCH, 2016, 46 (08) : 765 - 774
  • [36] Nomogram for prediction of the international study Group of Liver Surgery (ISGLS) grade B/C Posthepatectomy liver failure in HBV-related hepatocellular carcinoma patients: an external validation and prospective application study
    Ye, Jia-zhou
    Mai, Rong-yun
    Guo, Wei-xing
    Wang, Yan-yan
    Ma, Liang
    Xiang, Bang-de
    Cheng, Shu-qun
    Li, Le-qun
    BMC CANCER, 2020, 20 (01)